Neuroleptic Malignant Syndrome-like Reaction Precipitated by Antipsychotics in a Patient With Gamma-butyrolactone Withdrawal

    loading  Checking for direct PDF access through Ovid


We report the case of a patient with chronic abuse of gamma-butyrolactone (GBL, 3 bottles per week for 4 months), who in the course of the management of acute agitation and hallucinations developed symptoms compatible with both neuroleptic malignant syndrome and GBL withdrawal symptoms.

Some GHB withdrawal symptoms are similar to those of neuroleptic malignant syndrome, and the administration of antipsychotics might worsen the neurological condition of patients. So, it seems important to rapidly detect drugs taken by patients with mental agitation, to optimize management and minimize complications related to drugs.

Related Topics

    loading  Loading Related Articles